SG11202006943TA - Crystalline forms of the cxcr7 receptor antagonist (3s,4s)-1-cyclopropylmethyl-4-{[5-(2,4-difluoro-phenyl)-isoxazole-3-carbonyl]-amino}-piperidine-3-carboxylic acid (1-pyrimidin-2-yl-cyclopropyl)-amide - Google Patents
Crystalline forms of the cxcr7 receptor antagonist (3s,4s)-1-cyclopropylmethyl-4-{[5-(2,4-difluoro-phenyl)-isoxazole-3-carbonyl]-amino}-piperidine-3-carboxylic acid (1-pyrimidin-2-yl-cyclopropyl)-amideInfo
- Publication number
- SG11202006943TA SG11202006943TA SG11202006943TA SG11202006943TA SG11202006943TA SG 11202006943T A SG11202006943T A SG 11202006943TA SG 11202006943T A SG11202006943T A SG 11202006943TA SG 11202006943T A SG11202006943T A SG 11202006943TA SG 11202006943T A SG11202006943T A SG 11202006943TA
- Authority
- SG
- Singapore
- Prior art keywords
- cyclopropylmethyl
- isoxazole
- pyrimidin
- difluoro
- cyclopropyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP2018051938 | 2018-01-26 | ||
| PCT/EP2019/051819 WO2019145460A1 (en) | 2018-01-26 | 2019-01-25 | Crystalline forms of the cxcr7 receptor antagonist (3s,4s)-1-cyclopropylmethyl-4-{[5-(2,4-difluoro-phenyl)-isoxazole-3-carbonyl]-amino}-piperidine-3-carboxylic acid (1-pyrimidin-2-yl-cyclopropyl)-amide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202006943TA true SG11202006943TA (en) | 2020-08-28 |
Family
ID=65139016
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202006943TA SG11202006943TA (en) | 2018-01-26 | 2019-01-25 | Crystalline forms of the cxcr7 receptor antagonist (3s,4s)-1-cyclopropylmethyl-4-{[5-(2,4-difluoro-phenyl)-isoxazole-3-carbonyl]-amino}-piperidine-3-carboxylic acid (1-pyrimidin-2-yl-cyclopropyl)-amide |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US11339148B2 (en) |
| EP (1) | EP3743422B1 (en) |
| JP (1) | JP7076010B2 (en) |
| KR (1) | KR102502046B1 (en) |
| CN (1) | CN111683945B (en) |
| AU (1) | AU2019212888B8 (en) |
| BR (1) | BR112020015024A2 (en) |
| CA (1) | CA3088478A1 (en) |
| CL (1) | CL2020001928A1 (en) |
| EA (1) | EA202091746A1 (en) |
| IL (1) | IL276227A (en) |
| MA (1) | MA51664A (en) |
| MX (1) | MX2020007881A (en) |
| PH (1) | PH12020551121A1 (en) |
| SG (1) | SG11202006943TA (en) |
| TW (1) | TWI822724B (en) |
| UA (1) | UA125327C2 (en) |
| WO (1) | WO2019145460A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA037507B1 (en) | 2016-07-28 | 2021-04-06 | Идорсия Фармасьютиклз Лтд | Piperidine cxcr7 receptor modulators |
| JP2023501217A (en) | 2019-10-31 | 2023-01-18 | イドーシア ファーマシューティカルズ リミテッド | Combinations of CXCR7 antagonists with S1P1 receptor modulators |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2431357A3 (en) | 2002-11-27 | 2012-08-22 | Incyte Corporation | 3-Aminopyrrolidine Derivatives as Modulators of Chemokine Receptors |
| TW200526626A (en) | 2003-09-13 | 2005-08-16 | Astrazeneca Ab | Chemical compounds |
| EP1670739A4 (en) | 2003-10-08 | 2007-08-08 | Bristol Myers Squibb Co | Cyclic diamines and derivatives as factor xa inhibitors |
| CN101163693B (en) | 2005-02-18 | 2013-03-06 | 阿斯利康(瑞典)有限公司 | Antibacterial piperidine derivatives |
| US20090069288A1 (en) | 2007-07-16 | 2009-03-12 | Breinlinger Eric C | Novel therapeutic compounds |
| US8921398B2 (en) | 2011-06-09 | 2014-12-30 | Boehringer Ingelheim International Gmbh | N-cyclopropyl-N-piperidinyl-amide derivatives, pharmaceutical compositions and uses thereof |
| WO2013084241A1 (en) | 2011-12-09 | 2013-06-13 | Cadila Healthcare Limited | Compounds as inhibitors of renin |
| AR091516A1 (en) | 2012-06-22 | 2015-02-11 | Actelion Pharmaceuticals Ltd | DERIVATIVES OF 1- [M-CARBOXAMIDO (HETERO) ARIL-METIL] -HETEROCICLIL-CARBOXAMIDA |
| AU2013352304C1 (en) * | 2012-11-29 | 2018-03-22 | Chemocentryx, Inc. | CXCR7 antagonists |
| SG11201509057UA (en) | 2013-05-30 | 2015-12-30 | Actelion Pharmaceuticals Ltd | Cxcr7 receptor modulators |
| EA029901B1 (en) | 2013-09-04 | 2018-05-31 | Бристол-Майерс Сквибб Компани | Compounds useful as immunomodulators |
| RS57508B1 (en) | 2013-09-06 | 2018-10-31 | Aurigene Discovery Tech Ltd | 1,2,4-oxadiazole derivatives as immunomodulators |
| WO2015044900A1 (en) | 2013-09-27 | 2015-04-02 | Aurigene Discovery Technologies Limited | Therapeutic immunomodulating compounds |
| CA2960273A1 (en) | 2014-09-10 | 2016-03-17 | Epizyme, Inc. | Substituted pyrrolidine compounds |
| US10577363B2 (en) * | 2014-09-10 | 2020-03-03 | Epizyme, Inc. | Substituted piperidine compounds |
| EP3227263B1 (en) * | 2014-12-01 | 2019-04-10 | Idorsia Pharmaceuticals Ltd | Cxcr7 receptor modulators |
| EA037507B1 (en) | 2016-07-28 | 2021-04-06 | Идорсия Фармасьютиклз Лтд | Piperidine cxcr7 receptor modulators |
-
2019
- 2019-01-25 AU AU2019212888A patent/AU2019212888B8/en active Active
- 2019-01-25 MA MA051664A patent/MA51664A/en unknown
- 2019-01-25 TW TW108102825A patent/TWI822724B/en active
- 2019-01-25 WO PCT/EP2019/051819 patent/WO2019145460A1/en unknown
- 2019-01-25 MX MX2020007881A patent/MX2020007881A/en unknown
- 2019-01-25 EA EA202091746A patent/EA202091746A1/en unknown
- 2019-01-25 UA UAA202005451A patent/UA125327C2/en unknown
- 2019-01-25 SG SG11202006943TA patent/SG11202006943TA/en unknown
- 2019-01-25 CA CA3088478A patent/CA3088478A1/en active Pending
- 2019-01-25 US US16/964,885 patent/US11339148B2/en active Active
- 2019-01-25 JP JP2020560586A patent/JP7076010B2/en active Active
- 2019-01-25 BR BR112020015024-0A patent/BR112020015024A2/en unknown
- 2019-01-25 KR KR1020207024352A patent/KR102502046B1/en active IP Right Grant
- 2019-01-25 EP EP19701240.4A patent/EP3743422B1/en active Active
- 2019-01-25 CN CN201980010015.7A patent/CN111683945B/en active Active
-
2020
- 2020-07-22 IL IL276227A patent/IL276227A/en unknown
- 2020-07-23 CL CL2020001928A patent/CL2020001928A1/en unknown
- 2020-07-24 PH PH12020551121A patent/PH12020551121A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP7076010B2 (en) | 2022-05-26 |
| MX2020007881A (en) | 2022-06-02 |
| EP3743422B1 (en) | 2024-03-13 |
| KR20200116115A (en) | 2020-10-08 |
| AU2019212888A1 (en) | 2020-09-10 |
| US11339148B2 (en) | 2022-05-24 |
| CL2020001928A1 (en) | 2020-12-18 |
| UA125327C2 (en) | 2022-02-16 |
| US20210115033A1 (en) | 2021-04-22 |
| CN111683945B (en) | 2023-11-10 |
| TW201932460A (en) | 2019-08-16 |
| MA51664A (en) | 2021-05-05 |
| AU2019212888B2 (en) | 2023-12-21 |
| EP3743422C0 (en) | 2024-03-13 |
| JP2021511382A (en) | 2021-05-06 |
| TWI822724B (en) | 2023-11-21 |
| KR102502046B1 (en) | 2023-02-20 |
| CN111683945A (en) | 2020-09-18 |
| EA202091746A1 (en) | 2020-11-26 |
| CA3088478A1 (en) | 2019-08-01 |
| PH12020551121A1 (en) | 2021-05-31 |
| AU2019212888B8 (en) | 2024-01-04 |
| BR112020015024A2 (en) | 2021-01-19 |
| WO2019145460A1 (en) | 2019-08-01 |
| EP3743422A1 (en) | 2020-12-02 |
| IL276227A (en) | 2020-09-30 |
| AU2019212888A8 (en) | 2024-01-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2020008367A (en) | Novel crystalline forms. | |
| EP3826990A4 (en) | Compounds as neurokinin-1 receptor antagonists and uses thereof | |
| HK1258053A1 (en) | Novel 2,3,5-substituted thiophene compound as protein kinase inhibitor | |
| IL276227A (en) | Crystalline forms of the cxcr7 receptor antagonist (3s,4s)-1-cyclopropylmethyl-4-{[5-(2,4-difluoro-phenyl)-isoxazole-3-carbonyl]-amino}-piperidine-3-carboxylic acid (1-pyrimidin-2-yl-cyclopropyl)-amide | |
| ZA201804387B (en) | Pharmaceutical composition containing 2-{4-[n-(5,6- diphenylpyrazin-2-yl)-n-isopropylamino]butyloxy}-n- (methylsulfonyl)acetamide | |
| EP3825308C0 (en) | Thiohydantoin compound, composition, and use thereof as androgen receptor antagonists | |
| EP3919490A4 (en) | Five-and-six-membered heterocyclic compound and use thereof as protein receptor kinase inhibitor | |
| EP3911323A4 (en) | Heterocyclic compounds as adenosine antagonists | |
| HK1243416A1 (en) | Crystalline forms of 1-((2r,4r)-2-(1h-benzo[d]imidazol-2-yl)-1-methylpiperidin-4-yl)-3-(4-cyanophenyl)urea maleate | |
| EP3303323A4 (en) | 3,3-difluoropiperidine carbamate heterocyclic compounds as nr2b nmda receptor antagonists | |
| IL287026A (en) | Heterocyclic compounds and uses thereof | |
| IL284762A (en) | Heterocyclic compounds as adenosine antagonists | |
| EP3952875A4 (en) | Heterocyclic compounds and uses thereof | |
| EP3741753A4 (en) | Substituted diamino heterocyclic carboxamide compound and a composition containing the compound and use thereof | |
| EP4249072A3 (en) | Crystalline forms of quinolone analogs and their salts | |
| EP3882247A4 (en) | Six-membered and six-membered heterocyclic compound and uses thereof serving as protein receptor kinase inhibitor | |
| IL264708B (en) | Substituted n-[2-(4-phenoxypiperidin-1-yl)-2-(1,3-thiazol-5-yl)ethyl]benzamide and n-[2-(4-benzyloxypiperidin-1-yl)-2-(1,3-thiazol-5-yl)ethyl]benzamide derivatives p2x7 receptor antagonists | |
| EP3952879A4 (en) | Heterocyclic compounds and uses thereof | |
| EP3952878A4 (en) | Heterocyclic compounds and uses thereof | |
| EP3849604A4 (en) | Methods for decreasing influenza-induced lethality using gastrin-releasing peptide (grp) inhibitors or gastrin-releasing peptide receptor (grpr) antagonists | |
| TN2017000248A1 (en) | Cgrp antagonist peptides | |
| EP3812384A4 (en) | Maleate of benzothiophene compound, crystalline form thereof and use thereof | |
| UA40211S (en) | SOFT BULK CONTAINER | |
| AU2019900197A0 (en) | Modified angiotensin receptor agonists and uses thereof | |
| UA98919U (en) | 4-ethyl3-(phenoxymethyl)-5-((2-((5-phenoxymethyl)-4-phenyl-4h-1,2,4-triazole-3-il)thio)ethyl)thio)-4h-1,2,4-triazole, exhibiting diuretic activity |